Your browser doesn't support javascript.
loading
Association of Yersinia Infection With Kawasaki Disease: A Prospective Multicenter Cohort Study.
Hayashi, Hiroshi; Uda, Kazuhiro; Araki, Yumi; Akahoshi, Shogo; Tanaka, Miki; Miyata, Koichi; Hataya, Hiroshi; Miura, Masaru.
Afiliação
  • Hayashi H; From the Department of General Pediatrics.
  • Uda K; Clinical Research Support Center, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Araki Y; Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Akahoshi S; Department of Pediatrics, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Tanaka M; From the Department of General Pediatrics.
  • Miyata K; Clinical Research Support Center, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Hataya H; Department of Pediatrics, Tokyo Metropolitan Tama-Hokubu Medical Center, Tokyo, Japan.
  • Miura M; Department of Pediatrics, Tokyo Metropolitan Tama-Hokubu Medical Center, Tokyo, Japan.
Pediatr Infect Dis J ; 42(12): 1041-1044, 2023 Dec 01.
Article em En | MEDLINE | ID: mdl-37725804
BACKGROUND: Yersinia infection is known to present with Kawasaki disease (KD)-like symptoms although differentiating the 2 has been a challenge. The present study aimed to describe the clinical characteristics and prevalence of Yersinia infection presenting with KD-like symptoms. METHODS: The present, prospective, multicenter study enrolled patients who received a diagnosis of KD between January 2021 and January 2022 at 2 hospitals in Tokyo. Stool samples were collected within 3 days of the start of KD treatment, and cultures were performed for Yersinia . Clinical history and symptoms suggestive of Yersinia infection were also evaluated. RESULTS: During the study period, 141 KD patients were screened and 117 patients with evaluable stool samples were registered. Only 1 patient was positive for Yersinia pseudotuberculosis , which was detected from both stool and blood cultures. The patient was refractory to KD treatment but improved after initiation of appropriate antibiotic therapy. CONCLUSIONS: Routine screening for Yersinia is not appropriate for patients with KD and should be limited to certain patients in high-risk areas and those who are refractory to the standard KD treatment.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Yersiniose / Yersinia pseudotuberculosis / Infecções por Yersinia pseudotuberculosis / Síndrome de Linfonodos Mucocutâneos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Yersiniose / Yersinia pseudotuberculosis / Infecções por Yersinia pseudotuberculosis / Síndrome de Linfonodos Mucocutâneos Idioma: En Ano de publicação: 2023 Tipo de documento: Article